Q4 2021 Holdings
Filed 2022-02-14 | 87 holdings | $36.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lineage Cell Therapeutics in(LCTX) | COM | 53566P109 | $196 | 80,000 | 0.0% |
| Genfit S A | ADS | 372279109 | $302 | 60,448 | 0.0% |
| Surgalign Holdings Inc | COM | 86882C105 | $415 | 579,710 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $475 | 5,600 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $490 | 100,000 | 0.0% |
| Inogen Inc(INGN) | COM | 45780L104 | $510 | 15,000 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $528 | 36,720 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $531 | 236,160 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $670 | 45,000 | 0.0% |
| Proqr Therapeutics N V | SHS EURO | N71542109 | $685 | 85,476 | 0.0% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $740 | 121,242 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $747 | 320,444 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $757 | 70,177 | 0.0% |
| Lava Therapeutics NV | SHS | N51517105 | $766 | 139,332 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $794 | 105,163 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $820 | 732,500 | 0.0% |
| Field Trip Health LTD | COM | 31656R102 | $839 | 340,900 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $866 | 201,502 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $872 | 140,263 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $878 | 3,000 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $988 | 378,611 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $1.1K | 187,696 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $1.2K | 390,161 | 0.0% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $1.2K | 97,500 | 0.0% |
| Aerie Pharmaceuticals Inc | NOTE 1.500%10/0 | 00771VAB4 | $1.2K | $1,500,000 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $1.3K | 191,978 | 0.0% |
| Neuronetics Inc(STIM) | COM | 64131A105 | $1.4K | 313,717 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $1.4K | 80,485 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $1.4K | 90,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $1.5K | 315,000 | 0.0% |
| Brainsway LTD(BWAY) | SPONSORED ADS | 10501L106 | $1.5K | 200,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.6K | 110,829 | 0.0% |
| Venus Concept Inc | COM | 92332W105 | $1.7K | 975,687 | 0.0% |
| Regulus Therapeutics Inc | COM NEW | 75915K200 | $1.8K | 5,555,555 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $1.8K | 1,126,613 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $1.9K | 106,453 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $1.9K | 144,653 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $2.0K | 289,040 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.1K | 447,400 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $2.1K | 160,983 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.2K | 46,452 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $2.3K | 879,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $2.4K | 42,675 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $2.5K | 54,090 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.5K | 190,663 | 0.0% |
| Affimed N V | COM | N01045108 | $3.2K | 571,282 | 0.0% |
| F-Star Therapeutics Inc | COM | 30315R107 | $3.5K | 693,785 | 0.0% |
| Pardes Biosciences Inc | COM | 69945Q105 | $3.8K | 233,500 | 0.0% |
| Radius Health Inc | NOTE 3.000% 9/0 | 750469AA6 | $3.9K | $4,000,000 | 0.0% |
| Natus MED Inc | COM | 639050103 | $4.5K | 190,635 | 0.0% |